Accessibility Menu
 
Johnson & Johnson logo

Johnson & Johnson

(NYSE) JNJ

Current Price$238.32
Market Cap$574.36B
Since IPO (1968)+129,543%
5 Year+70%
1 Year+65%
1 Month-2%

Johnson & Johnson Financials at a Glance

Market Cap

$574.36B

Revenue (TTM)

$94.19B

Net Income (TTM)

$26.80B

EPS (TTM)

$11.05

P/E Ratio

21.59

Dividend

$5.20

Beta (Volatility)

0.20 (Low)

Price

$238.32

Volume

251,673

Open

$242.15

Previous Close

$238.32

Daily Range

$237.90 - $242.26

52-Week Range

$146.12 - $251.71

JNJ: Motley Fool Moneyball Superscore

74

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Johnson & Johnson

Industry

Pharmaceuticals

Employees

140,800

CEO

Joaquin Duato, MBA

Headquarters

New Brunswick, NJ 08933, US

JNJ Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

27%

Net Income Margin

28%

Return on Equity

35%

Return on Capital

18%

Return on Assets

13%

Earnings Yield

4.63%

Dividend Yield

0.02%

Payout Ratio

46.19%

Stock Overview

Market Cap

$574.36B

Shares Outstanding

2.41B

Volume

251.67K

Short Interest

0.00%

Avg. Volume

8.79M

Financials (TTM)

Gross Profit

$68.56B

Operating Income

$25.60B

EBITDA

$39.90B

Operating Cash Flow

$24.53B

Capital Expenditure

$4.83B

Free Cash Flow

$19.70B

Cash & ST Invst.

$20.10B

Total Debt

$47.93B

Johnson & Johnson Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$24.56B

+9.1%

Gross Profit

$21.22B

+37.8%

Gross Margin

86.37%

N/A

Market Cap

$574.36B

N/A

Market Cap/Employee

$4.16M

N/A

Employees

138,100

N/A

Net Income

$5.12B

+49.1%

EBITDA

$6.21B

+4.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$27.83B

-129.8%

Accounts Receivable

$17.18B

-9.2%

Inventory

$14.19B

+14.0%

Long Term Debt

$39.44B

+28.7%

Short Term Debt

$8.49B

+42.0%

Return on Assets

13.46%

N/A

Return on Invested Capital

17.64%

N/A

Free Cash Flow

$5.47B

+13.1%

Operating Cash Flow

$7.31B

+4.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ABBVAbbVie Inc.
$208.05-2.05%
AZNAstraZeneca PLC
$204.03-0.47%
MRKMerck & Co., Inc.
$121.42-1.03%
NVSNovartis AG
$154.05-0.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$49.17+0.00%

Questions About JNJ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.